Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Vertex Pharmaceuticals Inc (NASDAQ:VRTX)

84.00
Delayed Data
As of May 05
 +3.37 / +4.18%
Today’s Change
75.90
Today|||52-Week Range
143.45
-33.24%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2015
Quarter 3
2015
Quarter 4
2015
Quarter 1
2016
Revenue and IncomeNet Revenues166.1M309.8M417.9M398.1M
 
 
 
 
 
Cost of Goods Sold2.8M15.8M48.7M50.6M
 
 
 
 
 
Depreciation And Amortization14.1M16.2M15.7M--
 
 
 
 
 
Operating ExpensesGross Income149.2M277.9M353.5M347.4M
 
 
 
 
 
General Expenses318.3M346.1M407.5M361.1M
 
 
 
 
 
Research And Development223.9M246.3M310.4M255.9M
 
 
 
 
 
Total Operating Expenses335.1M378.0M471.9M411.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-169.0M-68.2M-54.0M-13.6M
 
 
 
 
 
Extraordinary Charge-2.1M-1.8M-1.5M-687.0K
 
 
 
 
 
Interest Expense On Debt21.1M21.1M20.7M20.7M
 
 
 
 
 
Other Expenses1.4M-1.3M-1.7M4.4M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-190.9M-92.5M-77.8M-30.6M
 
 
 
 
 
Income Taxes-30.1M-1.3M-1.4M-5.5M
 
 
 
 
 
Minority Interest-32.1M-1.3M-938.0K-5.5M
 
 
 
 
 
Net Income-188.8M-95.1M-75.5M-41.6M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS240.8M242.0M243.0M243.8M
 
 
 
 
 
Shares To Calculate EPS Diluted240.8M242.0M243.0M243.8M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.78-$0.39-$0.31-$0.17
 
 
 
 
 
EPS Diluted-$0.78-$0.39-$0.31-$0.17